SecBot SecBot
SC 13G ·Filed Nov 10, 2026

COLL

COLLEGIUM PHARMACEUTICAL, INC
NEUTRAL
Impact 3/10
Horizonweeks Processed6d 20h ago SEC0000093751-26-000632
Passive investor 5%+ stake
Actionable Insight • Neutral

State Street's passive stake disclosure adds to a mixed institutional picture: Millennium Management increased to 7.4% (Oct 8 filing) while Vanguard and Principal Global Investors reduced below 5% (late Oct filings). Monitor for any future 13D conversion or further stake changes from State Street, though the passive certification makes activist intent unlikely.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$24.47
T+0 close · Nov 10, 2026 · via day close
Latest settled
+1.39%
T+1 · $24.81
Vs SPY
+0.07%
α at T+1
Next horizon
T+5
in 4h
  1. T+0 · Nov 10 $24.47entry
  2. T+1 · 6d ago +1.39%α +0.07% · $24.81
  3. T+4 · todayOpen
  4. T+5 · in 4h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

State Street Corp filed a Schedule 13G disclosing a 5.4% passive stake in Collegium Pharmaceutical as of September 30, 2026, holding 1,772,243 shares. This is a new 5%+ disclosure by a major custodian bank and asset manager, adding to a mixed pattern of recent institutional stake changes at Collegium.

Key Financial Metrics

Stake
5.4%
Investor
STATE STREET CORP
Investor Type
mutual fund

Key Facts

  • State Street Corp disclosed a 5.4% passive beneficial ownership stake in Collegium Pharmaceutical as of September 30, 2026
  • State Street holds 1,772,243 shares of Collegium common stock
  • The filing certifies passive intent under Rule 13d-1(b), with no intent to influence control
  • This is a new 5%+ disclosure; State Street was not previously a reported 5% holder in the cross-filing context
  • The filing comes 5 days after Collegium reported Q3 2026 earnings (revenue $216.3M, adjusted EPS $1.96 beating $1.86 consensus)

Financial Impact

State Street's 5.4% stake is valued at approximately $40.6M based on the $752M market cap

ownership

Risk Factors

  • Passive 13G filing carries no activist intent, limiting near-term catalyst potential
  • State Street is primarily a custodian/index fund manager; the stake may reflect passive fund flows rather than active conviction

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000093751-26-000632
Document: 0000093751-26-000632-index.html0000093751-26-000632
Document: 0000093751-26-000632.txt0000093751-26-000632

Track record

24 reports on COLL

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +0.28% at T+1 after the Aug 13, 2026 report. 1 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $25.68 Now $25.43 −0.97% settles Nov 17
  2. Nov 10, 20266d ago SC 13G/A Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $24.47 to $24.81 Now $25.43 +3.92% ▲ +1.39% +0.07% vs SPY
  4. Nov 9, 20267d ago Institutional Cluster Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
  5. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  6. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $25.16 to $24.21 Now $25.43 +1.07% ▼ −3.78% −4.09% vs SPY
  7. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $23.80 to $23.68 Now $25.43 +6.85% ▼ −0.50% −0.03% vs SPY
  8. Oct 29, 202618d ago SC 13G/A Neutral 3/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
  9. Oct 29, 202618d ago Press Release Neutral 2/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
  10. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $23.50 to $22.96 Now $25.43 +8.21% ▼ −2.30% −1.78% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens in 6h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026